United Services Automobile Association Trevena Inc Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$0.51 - $1.88 $78,783 - $290,418	-154,478 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$0.39 - $3.47 $4,295 - $38,222	-11,015 Reduced 6.66%	154,478 $66,000
Q3 2018 Nov 13, 2018	SELL	$1.39 - $2.25 $3,405 - $5,512	-2,450 Reduced 1.46%	165,493 $351,000
Q2 2018 Sep 27, 2018	SELL	$1.44 - $2.24 $315,570 - $490,887	-219,146 Reduced 56.61%	167,943 $242,000
Q2 2018 Aug 10, 2018	BUY	$1.44 - $2.24 $309,435 - $481,344	214,886 Added 124.79%	387,089 $12.3 Million
Q1 2018 May 14, 2018	BUY	$1.51 - $2.06 $3,584 - $4,890	2,374 Added 1.4%	172,203 $282,000
Q4 2017 Feb 14, 2018	BUY	$1.4 - $2.6 $7,610 - $14,133	5,436 Added 3.31%	169,829 $272,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $364,952 - $458,656	164,393	164,393 $419,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $295M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.